Minnesota Attorney General Keith Ellison and pharmaceutical company Novo Nordisk reached a settlement to cap insulin costs at $35 per month. The Novo Nordisk settlement reached on Jan. 27 ...
By contrast, Novo Nordisk is both the developer and seller of Wegovy, while Viking Therapeutics's VK2735 has posted impressive results in testing and is now in the later stages of development. Wegovy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback